OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine Murphy, Kelly D. DeMarco, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 872-892
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The senescence-associated secretory phenotype and its physiological and pathological implications
Boshi Wang, Jin Han, Jennifer H. Elisseeff, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 12, pp. 958-978
Closed Access | Times Cited: 127

Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy
Chengming Qu, Haitao Yuan, Ming Tian, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4019-4037
Closed Access | Times Cited: 19

Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
Yi Huang, Zhijian J. Chen, Gang Shen, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 13

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D. DeMarco, Christina F. Lusi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 762
Open Access | Times Cited: 12

The role of the dynamic epigenetic landscape in senescence: orchestrating SASP expression
Nirmalya Dasgupta, Rouven Arnold, Anaïs Equey, et al.
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9

Overexpression of Malat1 drives metastasis through inflammatory reprogramming of the tumor microenvironment
Elena Martínez‐Terroba, Leah Plasek, Ioannis Chiotakakos, et al.
Science Immunology (2024) Vol. 9, Iss. 96
Closed Access | Times Cited: 8

Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8

Epigenetic developmental mechanisms underlying sex differences in cancer
Joshua B. Rubin, Tamara Abou-Antoun, Joseph E. Ippolito, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 8

Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1

A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1

Combined use of NK cells and radiotherapy in the treatment of solid tumors
Zheng Wang, Sunkai Ling, Yuandong Cao, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7

Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
Yue Liu, Isabelle Lomeli, Stephen J. Kron
Cells (2024) Vol. 13, Iss. 15, pp. 1281-1281
Open Access | Times Cited: 7

The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Alexander Lekan, Louis M. Weiner
Cancers (2024) Vol. 16, Iss. 3, pp. 559-559
Open Access | Times Cited: 6

Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy
Chenglin Liang, Ge Zhang, Linlin Guo, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 1, pp. 100888-100888
Open Access | Times Cited: 6

Therapy-induced senescence through the redox lens
Matius Robert, Brian K. Kennedy, Karen Crasta
Redox Biology (2024) Vol. 74, pp. 103228-103228
Open Access | Times Cited: 5

Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression
Rong He, Yifan Liu, Weijie Fu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

SMARCA4 regulates the NK-mediated killing of senescent cells
Virinder Reen, Mariantonietta D’Ambrosio, Pia Pernille Søgaard, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex
Y Lin, Huan Jin, Yong She, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access

PD-L1 knockout or ZG16 overexpression inhibits PDAC progression and modulates TAM polarization
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Cellular senescence: from homeostasis to pathological implications and therapeutic strategies
Chunhong Li, Yixiao Yuan, YingDong Jia, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Occurrence of cellular senescence in chronic human shoulder tendinopathies and its attenuation ex vivo by inhibition of Enhancer of Zeste 2
Dominik Bühler, Morgane Hilpert, Andrea Barbero, et al.
Bone and Joint Research (2025) Vol. 14, Iss. 2, pp. 143-154
Open Access

Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
Bowei Liu, Zhigang Peng, Hao Zhang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top